530 likes | 951 Views
MR Image Guided Hyperthermia Gerhard Sennewald PhD, Munich, Germany Kazakh Medical Diagnostic Forum “ T echnological Innovations in radiology & functional diagnosis “ Astana, Kazakhstan , September 23 & 24 , 2014. Agenda. Agenda. BSD 2000 •3D Deep Regional Hyperthermia
E N D
MR Image Guided Hyperthermia Gerhard Sennewald PhD, Munich, Germany KazakhMedical Diagnostic Forum “Technological Innovations in radiology& functionaldiagnosis“ Astana, Kazakhstan, September 23 & 24, 2014
Agenda Agenda • BSD 2000•3D Deep Regional Hyperthermia • BSD 2000•3D-MR Image Guided Hyperthermia • SigmaHyperPlan / SigmaVision
Regional Hyperthermia Upper (front ) plate Antennas Lower (back ) plate Antennas capacitive systems radiative multi antenna systems Image courtesy of Dughiero et al. Image courtesy of Gellermann et al.
Regional Hyperthermia capacitive systems radiative multi antenna systems Image courtesy of Dughiero et al. Image courtesy of Gellermann et al.
Regional Hyperthermia Direction of the E-Fields capacitivesystems radiative multi antenna systems Image courtesy of Dughiero et al. Image courtesy of Gellermann et al.
BSD-2000 System Family BSD 2000 Basic System • BSD-2000-3D/MRSystem: • 3 Rings with 8 Antenna each • MRI Image Guided Thermometry BSD 2000 3D System
Regional Hyperthermia Functional Principle: 8 Antennas in 4 pairs
BSD 2000 Concept: Antenna Arrays • Sigma60Applicator: • 8 AntennaArray surrounding the Patient
BSD 2000 3D Applicator 24 Antennae in 3 Rings of 8 Antennas each
Lamp phantom Regional Hyperthermia
BSD 2000 3D Hyperthermia Treatment Suite
BSD-2000 Clinical Indications: • Pancreas • Abdominal • Prostate • Pelvic • Lung • etc…. • Cervix • Rectal • Bladder • Sarcoma
Temperature Monitoring • Invasive Thermometry • Intratumoral • Min. Invasive Thermometry • Intraluminal • Image Guided Thermometry • MRI-Thermometry
MR Image Guided Hyperthermia Dockable Patient Cart & 70 cm Bore
Thermometry – MR Controlled Hyperthermia
MR Hyperthermia Treatment Suite MRI Diagnostics Hyperthermia
MR Imaging Compatible Applicators • Sigma 30 MR • 8 antennae • 4 channels • 1 antenna ring • 27 x 25 cm long • Sigma Eye MR: • 24 antennae • 12 channels • 3 antenna rings • 37 x 54 x 48 cm long • Sigma 40 MR: • 16 antennae • 8 channels • 2 antenna rings • 42 x 38 cm long
Color overlaytodisplaythetemperaturechanges Total andDifference PRFS Timelinefeaturetomonitorthechronologicalsequenceofthetreatment T90 temperaturecalculation Timelinedocumentationforeachstep Thermometry
MR Guided PediatricHyperthermia Wessalowski et al.: The Lancet Oncology 2013 on GermCell Tumors Department ofPediatricOncology UMS Düsseldorf - Germany Wessalowski et al. Lancet Oncol. 2013
MR Guided PediatricHyperthermia Wessalowski et al. Lancet Oncol. 2013
MR Guided PediatricHyperthermia ApplicatorsofVarious Sizes OptimizePediatric Treatments Wessalowski et al. Lancet Oncol. 2013
MR Guided PediatricHyperthermia Pediatric Abdominal Treatment in Sigma 40 Applicator Wessalowski et al. Lancet Oncol. 2013
MR Guided PediatricHyperthermia CombiningHyperthermia & Chemo forRecurrentGermCell Tumors: • 44 Patients, All Non-Respondersto Standard Chemo Treatment, Treated in HyperPei Protocol Resulting in 25 Completeand 14 Partial Remissions Wessalowski et al. Lancet Oncol. 2013
MR Guided PediatricHyperthermia Editorial T. Olson in „The Lancet Oncology“ 2013: Hyperthermia in PediatricGermCell Tumors – a New Treatment Standard ? Wessalowski et al. Lancet Oncol. 2013
The Atzelsberg Clinical Trial Circle Ott OJ et al., 2009
The Atzelsberg Clinical Trial Circle Ott OJ et al., 2009
The Atzelsberg Clinical Trial Circle Ott OJ et al., 2009
The Atzelsberg Clinical Trial Circle • Development of Guidelines and Clinical Trials Ott OJ et al., 2009
RESECTION Radiotherapy PTV: depending on former Tx Dose: 45 Gy d 1-14 d 22-35 5-FU CIV (250 mg/m²/d) d2 d9 d23 d30 Oxaliplatin Bolus (50 mg/m²/d) d2 d5 d9 d12 d16 d19 d23 d26 d30 d33 Deep Regional Hyperthermia 1 2 3 4 5 6 Week The Atzelsberg Clinical Trial Circle O. Ott: RectalCancerHyRec Trial - Treatment Schedule - Trial isRecruting Recurrent & LocallyAdvancedRectalCancer Required Cases n =59 Ott OJ et al., 2009
The Atzelsberg Clinical Trial Circle R.D.Issels MD PhD: Randomized Phase III Trial on Postoperative PancreasCancer